These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30321553)

  • 1. The Impact of Agent Orange Exposure on Prostate Cancer Outcomes.
    Etheridge T; Liou JI; Downs TM; Abel EJ; Jarrard DF; Richards KA
    J Urol; 2019 Apr; 201(4):742-750. PubMed ID: 30321553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
    Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
    J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
    Anderson-Carter I; Posielski N; Liou JI; Khemees TA; Downs TM; Abel EJ; Jarrard DF; Richards KA
    Urol Oncol; 2019 Feb; 37(2):130-137. PubMed ID: 30528885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Agent Orange and prostate cancer: a pilot case-control study.
    Giri VN; Cassidy AE; Beebe-Dimmer J; Ellis L; Smith DC; Bock CH; Cooney KA
    Urology; 2004 Apr; 63(4):757-60; discussion 760-1. PubMed ID: 15072895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.
    Tsai HT; Keating NL; Van Den Eeden SK; Haque R; Cassidy-Bushrow AE; Ulcickas Yood M; Smith MR; Potosky AL
    J Urol; 2015 Jun; 193(6):1956-62. PubMed ID: 25524243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
    Everly L; Merrick GS; Allen ZA; Butler WM; Wallner K; Lief JH; Galbreath RW; Adamovich E
    Brachytherapy; 2009; 8(1):57-62. PubMed ID: 18955017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agent Orange and long-term outcomes after radical prostatectomy.
    Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
    Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
    Fu AZ; Tsai HT; Haque R; Yood MU; Cassidy-Bushrow AE; Van Den Eeden SK; Keating NL; Smith MR; Zhou Y; Aaronson DS; Potosky AL
    J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of skeletal-related events on survival in patients with metastatic prostate cancer prescribed androgen deprivation therapy.
    Wong KW; Ma WK; Wong CW; Wong MH; Tsang CF; Tsu HL; Ho KL; Yiu MK
    Hong Kong Med J; 2016 Apr; 22(2):106-15. PubMed ID: 26635306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events.
    Schmid M; Sammon JD; Reznor G; Kapoor V; Speed JM; Abdollah FA; Sood A; Chun FK; Kibel AS; Menon M; Fisch M; Sun M; Trinh QD
    BJU Int; 2016 Aug; 118(2):221-9. PubMed ID: 26074405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer.
    Falchook AD; Basak R; Mohiuddin JJ; Chen RC
    Cancer; 2016 Aug; 122(15):2341-9. PubMed ID: 27191936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stage at Presentation and Oncologic Outcomes for Agent Orange Exposed and Non-Exposed United States Veterans Diagnosed With Prostate Cancer.
    Tward AE; Tward JD
    Clin Genitourin Cancer; 2021 Aug; 19(4):369-369.e7. PubMed ID: 33731274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.
    Fosså SD; Wiklund F; Klepp O; Angelsen A; Solberg A; Damber JE; Hoyer M; Widmark A;
    Eur Urol; 2016 Oct; 70(4):684-691. PubMed ID: 27025586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study.
    Yi SW; Ohrr H
    Cancer; 2014 Dec; 120(23):3699-706. PubMed ID: 25103108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.
    Ross RW; Xie W; Regan MM; Pomerantz M; Nakabayashi M; Daskivich TJ; Sartor O; Taplin ME; Kantoff PW; Oh WK
    Cancer; 2008 Mar; 112(6):1247-53. PubMed ID: 18293426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection in veterans with a history of Agent Orange exposure.
    Zafar MB; Terris MK
    J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
    Rusthoven CG; Jones BL; Flaig TW; Crawford ED; Koshy M; Sher DJ; Mahmood U; Chen RC; Chapin BF; Kavanagh BD; Pugh TJ
    J Clin Oncol; 2016 Aug; 34(24):2835-42. PubMed ID: 27325855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.